These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20843911)

  • 1. Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial.
    Arnold LM; Clauw D; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    J Rheumatol; 2010 Dec; 37(12):2578-86. PubMed ID: 20843911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
    Arnold LM; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    Arthritis Res Ther; 2011 Jun; 13(3):R86. PubMed ID: 21668963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of duloxetine in patients with chronic low back pain.
    Skljarevski V; Desaiah D; Liu-Seifert H; Zhang Q; Chappell AS; Detke MJ; Iyengar S; Atkinson JH; Backonja M
    Spine (Phila Pa 1976); 2010 Jun; 35(13):E578-85. PubMed ID: 20461028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of duloxetine 30 mg/d in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study.
    Arnold LM; Zhang S; Pangallo BA
    Clin J Pain; 2012; 28(9):775-81. PubMed ID: 22971669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
    Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
    Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
    Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
    Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
    Clauw DJ; Mease P; Palmer RH; Gendreau RM; Wang Y
    Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
    Arnold LM; Pritchett YL; D'Souza DN; Kajdasz DK; Iyengar S; Wernicke JF
    J Womens Health (Larchmt); 2007 Oct; 16(8):1145-56. PubMed ID: 17937567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
    Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
    J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial.
    Skljarevski V; Zhang S; Desaiah D; Alaka KJ; Palacios S; Miazgowski T; Patrick K
    J Pain; 2010 Dec; 11(12):1282-90. PubMed ID: 20472510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.
    Russell JI; Mease PJ; Smith TR; Kajdasz DK; Wohlreich MM; Detke MJ; Walker DJ; Chappell AS; Arnold LM
    Pain; 2008 Jun; 136(3):432-444. PubMed ID: 18395345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
    Konno S; Oda N; Ochiai T; Alev L
    Spine (Phila Pa 1976); 2016 Nov; 41(22):1709-1717. PubMed ID: 27831985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.
    Murakami M; Osada K; Mizuno H; Ochiai T; Alev L; Nishioka K
    Arthritis Res Ther; 2015 Aug; 17(1):224. PubMed ID: 26296539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of duloxetine treatment on cognition in patients with fibromyalgia.
    Mohs R; Mease P; Arnold LM; Wang F; Ahl J; Gaynor PJ; Wohlreich MM
    Psychosom Med; 2012; 74(6):628-34. PubMed ID: 22753629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.
    Kornstein SG; Wohlreich MM; Mallinckrodt CH; Watkin JG; Stewart DE
    J Clin Psychiatry; 2006 May; 67(5):761-70. PubMed ID: 16841626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: results of a randomized, double-blind, placebo-controlled trial.
    Arnold LM; Gendreau RM; Palmer RH; Gendreau JF; Wang Y
    Arthritis Rheum; 2010 Sep; 62(9):2745-56. PubMed ID: 20496365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.
    Mallinckrodt CH; Prakash A; Andorn AC; Watkin JG; Wohlreich MM
    J Psychiatr Res; 2006 Jun; 40(4):337-48. PubMed ID: 16271726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.
    Arnold LM; Rosen A; Pritchett YL; D'Souza DN; Goldstein DJ; Iyengar S; Wernicke JF
    Pain; 2005 Dec; 119(1-3):5-15. PubMed ID: 16298061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.